From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest Views & News

Probiotix Health – “a year of continued strong growth”, and what's next?

By HotStockRockets | Friday 6 January 2023

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Probiotix Health (PBX), spun-off onto Aquis by OptiBiotix Health (OPTI) which retains a 44% shareholding, has issued a “Commercial and scientific update” including that “with growing sales, operational profitability, and a clear strategic focus on growing the business by commercialising ingredients and final products across more territories and more application areas with existing and new partners, we look forward to 2023 with great confidence and excitement”. What’s the detail from a current 21.5p share price, £26.2 million market cap?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



How is Wickes getting along?

Friday »


Tern – Is There More Bad News On The Way?

Thursday »


Zytronic – now a recovery Buy?



Buy Yourgene - target 0.6p



Keep avoiding Deliveroo shares

Friday »


Tharisa – Q1 report, still a value Buy



Sainsbury’s has a good Christmas